Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Virtual Speaker Program: A Customer Story

    White Papers and Resources | July 14, 2021 | Impetus Digital

    Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions.

    Impact of COVID-19 on the Biopsychosocial Model of Health

    Videos and Podcasts | July 8, 2021 | Impetus Digital

    Dr. Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and...

    Leaders in Pharma: Fran Milnes

    Videos and Podcasts | July 8, 2021 | Impetus Digital

    In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Fran Milnes. She is currently the Head of Marketing and Commercial Excellence in Oncology at Novartis.

    ‘Smear Word’ campaign for Roche aims to break taboos and save lives

    Press Releases | July 8, 2021 | Inizio

    An all-female team at Mind+Matter has created a campaign for Roche that takes a tongue-in-cheek approach to tackle taboos about going for a smear test.

    FREE eBook: The Complete Guide to Virtualizing In-person Meetings

    White Papers and Resources | July 5, 2021 | Impetus Digital

    Download our latest eBook for free to learn about the innovative ways clients have used our synchronous and asynchronous virtual tools to engage participants and virtualize their meetings and events.

    Starting a career in medical communications – experiences from the Nucleus Academy (part 2)

    Press Releases | July 5, 2021 | Nucleus Global

    Two more graduates of the Nucleus Academy training programme share their experiences of the Academy and their medical communications careers to date.

    The Spirit of Lucid Group

    Press Releases | July 2, 2021 | Lucid Group Communications Limited

    Since 2017, Lucid Group’s charity working group, LUCID SPIRIT, has been actively involved in helping to raise awareness and funds for its charity partners. At launch, Lucid Spirit partnered with the...

    Open-Data Platforms for Direct Engagement with Patients, Researchers, and Pharma

    Videos and Podcasts | July 1, 2021 | Impetus Digital

    Indu Navar, CEO and Founder of EverythingALS, explores the roles of Artificial Intelligence, Machine Learning, and Brain Computer Interface in the search for a cure for ALS. She will also...

    Moving Away from Hospital-Centered Care: Barriers & Opportunities

    Videos and Podcasts | July 1, 2021 | Impetus Digital

    David Barthel, CEO of Health Logic Interactive Inc., discusses their lab-on-chip, point-of-care platform technology for CKD. He also explores the issues with the hospital-centered model of care, shares his tips...

    WHITE PAPER: From bench to bedside in one year – how the race for a COVID-19 vaccine will change the future of drug development

    White Papers and Resources | July 1, 2021 | IGNIFI

    In this edition of MAGNIFI, we discuss the factors behind this acceleration in development of the COVID-19 vaccines and what this might mean for the future of pharma